Squarepoint’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Squarepoint’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-64,159	Closed	-$816K	–	4624
2023 Q3	$816K	Sell	64,159 -51,316	-44%	-$708K	﹤0.01%	2461
2023 Q2	$1.63M	Sell	115,475 -39,130	-25%	-$560K	0.01%	1806
2023 Q1	$2.39M	Buy	154,605 +81,859	+113%	+$1.37M	0.01%	1317
2022 Q4	$1.19M	Buy	72,746 +11,116	+18%	+$181K	﹤0.01%	1702
2022 Q3	$1.14M	Buy	+61,630	New	+$967K	0.01%	1679
2022 Q2	–	Sell	-18,394	Closed	-$171K	–	3529
2022 Q1	$171K	Sell	18,394 -60,538	-77%	-$515K	﹤0.01%	2512
2021 Q4	$771K	Buy	78,932 +65,542	+489%	+$1.23M	﹤0.01%	1867
2021 Q3	$455K	Sell	13,390 -3,348	-20%	-$107K	﹤0.01%	2017
2021 Q2	$613K	Sell	16,738 -773	-4%	-$29.9K	﹤0.01%	1993
2021 Q1	$785K	Buy	17,511 +4,458	+34%	+$208K	﹤0.01%	1702
2020 Q4	$745K	Buy	13,053 +3,879	+42%	+$230K	0.01%	1521
2020 Q3	$471K	Buy	+9,174	New	+$449K	0.01%	1478
2019 Q2	–	Sell	-47,971	Closed	-$1.11M	–	2739
2019 Q1	$1.11M	Buy	47,971 +8,665	+22%	+$227K	0.01%	1056
2018 Q4	$825K	Buy	39,306 +6,028	+18%	+$148K	0.01%	998
2018 Q3	$1.29M	Buy	33,278 +5,221	+19%	+$193K	0.02%	882
2018 Q2	$1.1M	Buy	+28,057	New	+$826K	0.01%	857

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Squarepoint's DCPH Position: Q4 2023 in Review

Squarepoint sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2023, closing a stake of 64,159 shares — an estimated $816K sold.

Squarepoint first reported a position in DCPH in Q2 2018 and held it in 16 quarters. The position peaked at $2.39M in Q1 2023. 164 funds tracked by Wall St. Rank hold DCPH as of Q4 2023.

Squarepoint reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Squarepoint sold 64,159 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $816K.
Squarepoint first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 16 quarters.
Squarepoint's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.39M in Q1 2023.
164 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Squarepoint's 13F filing for Q4 2023, filed 14 Feb 2024.